Development and pathology of pulmonary hypertension.
暂无分享,去创建一个
P. Thistlethwaite | R. Tuder | T. Braun | F. Capron | S. Abman | T. Stevens | S. Haworth
[1] P. Thistlethwaite,et al. Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[2] F. Maldonado,et al. Medical and Surgical Management of Chylothorax, a Review of 74 Consecutive Cases. , 2009, ATS 2009.
[3] W. Grizzle,et al. Histopathological Assessment of the First 9 Cases Collected by the Pulmonary Hypertension Breakthrough Initiative (PHBI). , 2009, ATS 2009.
[4] W. Grizzle,et al. Systematic Collection of Human Pulmonary Arterial Hypertension Lung Tissue: Methods of the Pulmonary Hypertension Breakthrough Initiative (PHBI). , 2009, ATS 2009.
[5] A. Klein,et al. Pulmonary endarterectomy , 2008, Current opinion in anaesthesiology.
[6] The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[7] S. Erzurum,et al. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[8] S. Abman,et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[9] Y. Shang,et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. , 2007, Journal of the American College of Cardiology.
[10] R. Tuder,et al. Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.
[11] W. Vainchenker,et al. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice , 2007, Respiratory research.
[12] Raed A Dweik,et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[13] David O. Martin,et al. Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up. , 2006, Journal of the American College of Cardiology.
[14] P. Thistlethwaite,et al. Molecular biology of chronic thromboembolic pulmonary hypertension. , 2006, Seminars in thoracic and cardiovascular surgery.
[15] A. Nicholson,et al. Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases , 2006, The American journal of surgical pathology.
[16] T. Stevens. Molecular and cellular determinants of lung endothelial cell heterogeneity. , 2005, Chest.
[17] A. Zaiman,et al. One hundred years of research in the pathogenesis of pulmonary hypertension. , 2005, American journal of respiratory cell and molecular biology.
[18] S. Archer,et al. Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury: Evidence That Angiogenesis Participates in Alveolarization , 2005, Circulation.
[19] M. Yoder,et al. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. , 2005, Blood.
[20] K. Stenmark,et al. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. , 2005, Annual review of physiology.
[21] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[22] Troy Stevens,et al. On lung endothelial cell heterogeneity. , 2004, Microvascular research.
[23] M. Humbert,et al. Pathologic assessment of vasculopathies in pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[24] Paolo Prandoni,et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.
[25] M. Frid,et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[26] R. Budhiraja,et al. Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.
[27] S. Phan,et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.
[28] A. Verin,et al. Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).
[29] W. Seeger,et al. Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth , 2003, Circulation research.
[30] P. Thistlethwaite,et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. , 2002, The Journal of thoracic and cardiovascular surgery.
[31] N. Voelkel,et al. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[32] R. Watkins,et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[33] R. Watkins,et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.
[34] S. Abman. Bronchopulmonary dysplasia: "a vascular hypothesis". , 2001, American journal of respiratory and critical care medicine.
[35] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] P. Friedman,et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. , 2000, American journal of respiratory and critical care medicine.
[37] R. Bland,et al. Chronic Lung Disease in Early Infancy , 2000 .
[38] N. Voelkel,et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[39] A. Hislop,et al. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. , 2000, American journal of respiratory cell and molecular biology.
[40] J. Shannon,et al. Tissue interactions mediate early events in pulmonary vasculogenesis , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.
[41] J. Coalson. 5. PATHOLOGY OF CHRONIC LUNG DISEASE OF EARLY INFANCY , 2000 .
[42] D. Stewart,et al. Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. , 1999, American journal of respiratory cell and molecular biology.
[43] G. Simonneau,et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[45] A. Hirsch,et al. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? , 1996, American journal of respiratory and critical care medicine.
[46] C. Wagenvoort,et al. Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .